Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Minerva Neurosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Title |
Fee Calculation Rule |
Amount Registered(1)(2) |
Proposed Maximum Offering Price Per Share(3) |
Maximum Price |
Fee Rate |
Amount of Registration Fee | |||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(c) | 2,000,575 | $8.96 | $17,925,152 | 0.00011020 | $1,975.35 | ||||||||
| Total Offering Amounts | $17,925,152 | $1,975.35 | ||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $1,975.35 | |||||||||||||||
| (1) | The shares of common stock will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement. |
| (2) | This registration statement registers the resale of (i) 1,425,000 outstanding shares of common stock of the Registrant held by the selling stockholders and (ii) 575,575 shares of common stock of the Registrant issuable upon the exercise of outstanding pre-funded warrants to purchase shares of common stock held by the selling stockholders. |
| (3) | Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based on average of high and low price per share of the common stock as reported on the Nasdaq Capital Market on July 28, 2023. |